Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Allen Andrew R Create: Alert

All | News | Filings
Date FiledTypeDescription
07/05/2023 4 Allen Andrew R (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 73,212 options to buy @ $0
Granted 56,868 options to buy @ $0
Granted 45,348 options to buy @ $0
Granted 109,746 options to buy @ $0
Granted 152,376 options to buy @ $0
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2023 3 Allen Andrew R (Director) has filed a Form 3 on Adaptimmune Therapeutics PLC
06/01/2023 4 Allen Andrew R (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Disposed/sold 16,800 options to buy @ $0.97, valued at $16.3k
Disposed/sold 12,100 options to buy @ $5.21, valued at $63k
Disposed/sold 12,100 options to buy @ $31.83, valued at $385.1k
Disposed/sold 5,000 options to buy @ $16.1, valued at $80.5k
Disposed/sold 6,270 options to buy @ $16.11, valued at $101k
Disposed/sold 8,072 options to buy @ $6.07, valued at $49k
02/06/2023 4 Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone bio, Inc.
Txns: Granted 738,550 shares @ $0
12/19/2022 4 Allen Andrew R (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 16,800 options to buy @ $0.97, valued at $16.3k
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2022 4 Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone bio, Inc.
Txns: Granted 70,000 shares @ $0
Granted 410,000 options to buy @ $5.46, valued at $2.2M
12/10/2021 4 Allen Andrew R (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 12,100 options to buy @ $5.21, valued at $63k
11/19/2021 4 Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone bio, Inc.
Txns: Granted 48,200 shares @ $0
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/10/2021 4 Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone Oncology, Inc.
Txns: Granted 290,000 options to buy @ $13.87, valued at $4M
12/11/2020 4 Allen Andrew R (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 12,100 options to buy @ $31.83, valued at $385.1k
06/10/2020 4 Allen Andrew R (Director) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Granted 12,030 options to buy @ $13.98, valued at $168.2k
06/02/2020 4 Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 14,013 options to buy @ $17.55, valued at $245.9k
03/18/2020 4 Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Exercised 12,500 options to buy @ $9.33, valued at $116.6k
12/20/2019 4 Allen Andrew R (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 5,000 options to buy @ $16.1, valued at $80.5k
06/12/2019 4 Allen Andrew R (Director) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Granted 30,000 options to buy @ $0.66, valued at $19.8k
06/07/2019 4 Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 17,633 options to buy @ $13.74, valued at $242.3k
04/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/14/2019 4 Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone Oncology, Inc.
Txns: Granted 180,000 options to buy @ $12.02, valued at $2.2M
02/13/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
12/11/2018 4 Allen Andrew R (Director) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Bought 66,000 shares @ $1.64, valued at $108.2k
09/27/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
06/14/2018 4 Allen Andrew R (Director) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Granted 25,000 options to buy @ $3.27, valued at $81.8k
05/31/2018 4 Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 12,500 options to buy @ $17, valued at $212.5k
11/13/2017 4 Allen Andrew R (Director) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Granted 50,000 options to buy @ $1.92, valued at $96k
10/25/2017 3 Allen Andrew R (Director) has filed a Form 3 on Sierra Oncology, Inc.
06/26/2017 4 Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 12,500 options to buy @ $13.65, valued at $170.6k
05/23/2016 4 Allen Andrew R (Director) has filed a Form 4 on Epizyme, Inc.
06/07/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/04/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/05/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy